CCND1 and breast carcinoma: We also found novel trans-enhancer hijacking events activating known oncogenes including MYC in the small cell lung cancer cell line NCIH146, NOTCH1 in the T-cell lymphoblastic leukemia cell line CUTLL1, and CCND1 in the breast cancer cell line ZR751.